======= FUT2 ======= == Gene Information == * **Official Symbol**: FUT2 * **Official Name**: fucosyltransferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2524|2524]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q10981|Q10981]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FUT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/182100|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a Golgi stack membrane protein that is involved in the creation of a precursor of the H antigen, which is required for the final step in the soluble A and B antigen synthesis pathway. This gene is one of two encoding the galactoside 2-L-fucosyltransferase enzyme. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]. Sequence Note: This RefSeq record represents the SE*01.01.01 allele. * **UniProt Summary**: Mediates the transfer of fucose to the terminal galactose on glycan chains of cell surface glycoproteins and glycolipids (PubMed:7876235). The resulting epitope plays a role in cell-cell interaction including host-microbe interaction (PubMed:12692541, PubMed:8018146). Mediates interaction with intestinal microbiota influencing its composition (PubMed:21625510, PubMed:24733310, PubMed:22068912). Creates a soluble precursor oligosaccharide FuC-alpha ((1,2)Galbeta-) called the H antigen which is an essential substrate for the final step in the soluble ABO blood group antigen synthesis pathway (PubMed:7876235). {ECO:0000269|PubMed:21625510, ECO:0000269|PubMed:22068912, ECO:0000269|PubMed:24733310, ECO:0000269|PubMed:7876235, ECO:0000269|PubMed:8018146}. |Glyco transf 11| |galactoside 2-alpha-L-fucosyltransferase activity| |L-fucose metabolic process| |fucose catabolic process| |fucosyltransferase activity| |L-fucose catabolic process| |fucose metabolic process| |fucosylation| |hexose catabolic process| |monosaccharide catabolic process| |Golgi cisterna membrane| |carbohydrate catabolic process| |hexose metabolic process| |monosaccharide metabolic process| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |small molecule catabolic process| |carbohydrate metabolic process| |carbohydrate derivative biosynthetic process| |Golgi apparatus| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |organic substance catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.73| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13963 * **Expression level (log2 read counts)**: 2.77 {{:chemogenomics:nalm6 dist.png?nolink |}}